Leukemia in Adults

Our experts use the latest techniques to diagnose and treat all forms of blood cancer, including leukemia, in which the abnormal growth of white blood cells causes cancer. We also treat neoplastic blood diseases, including myeloproliferative disorders and myelodysplastic syndromes, all of which are caused by an excessive growth of blood cells.

Through a collaborative approach, our multidisciplinary team of hematologists, oncologists, and pathologists provides personalized care and creates a treatment plan based on your particular diagnosis and individual needs.

To achieve the best possible outcomes, we offer the latest treatments, including chemotherapy, targeted therapy, stem cell transplants, epigenetic treatments, immunotherapy, and radiation therapy. Through clinical trials, our translational research program offers access to innovative treatments to patients. Our experts also work in close partnership with our Blood and Marrow Transplant Program to provide multiple treatment options.

Clinical Trials and Research Studies

Phase 1

A First in Human Study of theMenin-KMT2A (MLL1)Inhibitor JNJ-75276617 in Participants with Acute Leukemia

Learn More

Phase 6

A Multi-center Open-label Single-arm Phase 2/3 Trial Evaluating the Safety and Pharmacokinetics of Calaspargase Pegol for Treatment of Adults Aged 22 To >65 Years with Newly-diagnosed Philadelphia-negative ALL

Learn More

Phase 2

A Phase IIa Open-label Clinical Trial to Evaluate the Safety Pharmacokinetics Pharmacodynamics and Efficacy of BP1001 (a Liposomal Grb2 Antisense Oligonucleotide) in Combination with Venetoclax plus Decitabine in Patients with Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Induction Therapy

Learn More

Phase 3

AALL1631: International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Ph+ ALL Testing Imatinib in Combination with Two Different Cytotoxic Chemotherapy Backbones

Learn More